Impact of first wave of COVID-19 on outcomes of hospitalization for upper gastrointestinal bleeding in Hong Kong: a population-based study
Background and study aims The COVID-19 pandemic has caused a major disruption in the healthcare system. This study determined the impact of the first wave of COVID-19 on the number and outcome of patients hospitalized for upper gastrointestinal bleeding (UGIB) in Hong Kong.
Patients and methods Records of all patients hospitalized for UGIB in Hong Kong public hospitals between October 2018 and June 2020 were retrieved. The number and characteristics of patients hospitalized for UGIB after COVID-19 was compared by autoregressive integrated moving average (ARIMA) model prediction and historical cohort.
Results Since the first local case of COVID-19, there was an initial drop in UGIB hospitalizations (observed 29.8 vs predicted 35.5 per week; P = 0.05) followed by a rebound (39.8 vs 26.7 per week; P < 0.01) with a turning point at week 14 (Petitt’s test, P < 0.001). There was a negative association between the number of COVID-19 cases and the number of patients hospitalized for UGIB (Pearson correlation –0.53, P < 0.001). Patients admitted after the outbreak of COVID-19 had lower hemoglobin (7.5 vs baseline 8.3 g/dL; P < 0.01) and a greater need for blood transfusion (64.5 % vs baseline 50.4 %; P < 0.01), but similar rates of all-cause mortality (6.9 % vs 7.1 %; P = 0.82) and rebleeding (6.7 % vs 5.1 %; P = 0.11). There was also a higher proportion of patients with variceal bleeding (10.5 % vs baseline 5.3 %; P < 0 .01).
Conclusions There was a dynamic change in the number of patients hospitalized for UGIB in Hong Kong during the first wave of the COVID-19 outbreak, with more obvious impact during the initial phase only.
Eingereicht: 03. Juli 2020
Angenommen: 11. November 2020
18. Februar 2021 (online)
© 2021. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
- 1 Sagami R, Nishikiori H, Sato T. et al. Aerosols produced by upper gastrointestinal endoscopy: a quantitative evaluation. Am J Gastroenterol 2020; DOI: 10.14309/ajg.0000000000000983.
- 2 Kim J, Doyle JB, Blackett JW. et al. Effect of the Coronavirus 2019 Pandemic on outcomes for patients admitted with gastrointestinal bleeding in New York City. Gastroenterology 2020; 159: 1155-1157 , e1151
- 3 Schmiderer A, Schwaighofer H, Niederreiter L. et al. Decline in acute upper gastrointestinal bleeding during Covid-19 pandemic after lockdown in Austria. Endoscopy 2020; 52: 1036-1038
- 4 Lui TKL, Leung K, Guo CG. et al. Impacts of the Coronavirus 2019 Pandemic on gastrointestinal endoscopy volume and diagnosis of gastric and colorectal cancers: a population-based study. Gastroenterology 2020; 159: 1164-1166 , e1163
- 5 Guo CG, Cheung KS, Zhang F. et al. Incidences, temporal trends and risks of hospitalisation for gastrointestinal bleeding in new or chronic low-dose aspirin users after treatment for Helicobacter pylori: a territory-wide cohort study. Gut 2020; 69: 445-452
- 6 Chan EW, Lau WC, Leung WK. et al. Prevention of dabigatran-related gastrointestinal bleeding with gastroprotective agents: a population-based study. Gastroenterology 2015; 149: 586-595, e583
- 7 The Center for Health Protection of the Department of Health of Hong Kong. COVID-19 theme website. Verfügbar unter: https://www.coronavirus.gov.hk/eng/index.html